Investors Bet on Nuclear as Governments Push a ‘Golden Age’ of Power
Projections of rising capacity and government backing lift shares in Centrica, Rolls‑Royce and uranium plays, but long timelines and project risks temper enthusiasm.
Business & Markets News
OpenAI and Nvidia chiefs to join Trump state visit amid planned multibillion-dollar UK data centre pledges
Sam Altman and Jensen Huang are reported to be part of a US executive delegation expected to unveil billions in data-centre investment with London’s Nscale Global during President Donald Trump’s state visit.
Ellison family poised to pursue Warner Bros Discovery in reported £24 billion bid
Paramount Skydance, backed by Larry Ellison’s family capital, moves on a studio in the midst of strategic review as industry consolidation accelerates
Giorgio Armani's will orders sale or stock market listing of fashion house
Italian designer specified LVMH, L’Oréal or EssilorLuxottica as preferred buyers; foundation to retain 30% voting rights if public listing proceeds
Jaguar Land Rover cyber attack threatens suppliers with bankruptcies, calls for government furlough support
Two-week IT shutdown has halted UK production, disrupted parts supply and prompted warnings that smaller suppliers may collapse unless ministers act
AstraZeneca pauses £200m Cambridge expansion as UK pharma output falls
Planned project that would have created about 1,000 jobs is on hold amid industry withdrawals and warnings that Britain is becoming less attractive to drug companies
Pfizer and Moderna Shares Fall After Report That Administration Plans to Link 25 Child Deaths to COVID Vaccines
Stocks slipped as a report that officials will cite unverified VAERS reports in a presentation ahead of a CDC advisory meeting raised investor concern over policy and coverage implications
AstraZeneca pauses £200m Cambridge expansion, halting wider £650m UK package
The drugmaker suspended plans for a 1,000‑job research hub as pharmaceutical investment shifts toward the United States
Opendoor’s New Chairman Says He Will Cut Up to 85% of Workforce, Calls Company ‘Bloated’
Keith Rabois, returning to the iBuyer amid activist pressure, vows deep staff reductions and a return to in‑person work after leadership change and volatile stock moves